Inovio receives $71 million contract from u.s. department of defense

Inovio receives $71 million contract from u.s. department of defense to scale up manufacture of cellectra® 3psp smart device and procurement of cellectra® 2000 for covid-19 dna vaccine.inovio pharmaceuticals- government to support scale-up of co's proprietary intradermal dna delivery device cellectra 3psp to deliver co's covid-19 vaccine.inovio pharmaceuticals - to report on interim u.s. phase 1 clinical trial results in late june.inovio pharmaceuticals inc - preparing for u.s. phase 2/3 efficacy study to begin this summer.
INO Ratings Summary
INO Quant Ranking